1. Pat. 106101 UA, MPK A61K 33/08, A61P 31/22, A method of antiviral medical drugs production, which contain nanoparticles, and a drug against herpes virus hiv and influenza virus h1n1, which is produced via this method, Lokshyn, M. M., Spivak, M. Ya., Lysenko, V. S., Publ. 25.07.2014 [in Ukrainian].
2. Mazurkova, N. A., Spitsyna, Yu. E., Shikina, N. V., Ismagilov, Z. R., Zagrebel’nyi, S. N., & Ryabchikova, E. I. (2010). Interaction of titanium dioxide nanoparticles with influenza virus. Nanotechnologies in Russia, 5(5–6), 417–420. https://doi.org/10.1134/S1995078010050174
3. Kanhed, P., Birla, S., Gaikwad, S., Gade, A., Seabra, A. B., Rubilar, O. … Rai, M. (2014). In vitro antifungal efficacy of copper nanoparticles against selected crop pathogenic fungi. Materials Letters, 115, 13–17. https://doi.org/10.1016/j.matlet.2013. 10.011
4. Nasrollahi, A., Pourshamsian, Kh., Mansourkiaee, P. (2011). Antifungal activity of silver nanoparticles on some of fungi. International Journal of Nano Dimension, 1(3), 233–239. DOI:10.7508/ IJND.2010.03.007
5. Singh, G., Joyce, E. M., Beddow, J., & Mason, T. J. (2020). Evaluation of antibacterial activity of ZnO nanoparticles coated sonochemically onto textile fabrics. Journal of microbiology, biotechnology and food sciences, 9(4), 106–120.